HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 321 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $219,650 | +5.9% | 5,750 | 0.0% | 0.02% | +29.4% |
Q2 2023 | $207,403 | -8.0% | 5,750 | -2.5% | 0.02% | -26.1% |
Q1 2023 | $225,321 | -32.9% | 5,900 | 0.0% | 0.02% | -23.3% |
Q4 2022 | $335,710 | +44.1% | 5,900 | 0.0% | 0.03% | +36.4% |
Q3 2022 | $233,000 | +1.7% | 5,900 | +19.2% | 0.02% | +4.8% |
Q2 2022 | $229,000 | +12.3% | 4,950 | -2.5% | 0.02% | +31.2% |
Q4 2021 | $204,000 | – | 5,075 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |